Altre lingue Harbin Medisan Pharmaceutical Co., Ltd.

Azioni

002900

CNE1000032V9

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 04/07/2024			Variaz. 5gg	Var. 1 gen.
8,96 ^CNY	-3,55%		-4,07%	-34,36%

26/04	L'iniezione di cloruro di potassio di Medisan Pharma supera la valutazione dell'ente regolatore del farmaco	MT
25/04	Harbin Medisan Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Harbin Medisan Pharmaceutical Co., Ltd. Announces Final Dividend of A Shares for 2023, Payable on 05 June 2024	29/05
Harbin Medisan Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023	26/04
Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation	26/04
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Harbin Medisan Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022, Payable on May 31, 2023	17/05/23
Harbin Medisan Pharma Gets Patent Rights of China Pharmaceutical University-Developed Drug	04/05/23
Harbin Medisan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	26/04/23
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Harbin Medisan Pharmaceutical Co., Ltd. Approves Management Appointments	28/11/22
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22
Harbin Medisan Pharmaceutical Co., Ltd. Implements Final Cash Dividend for 2021, Payable on June 13, 2022	07/06/22
Harbin Medisan Pharmaceutical Co., Ltd. Approves Final Cash Dividend Proposal for 2021	18/05/22
Harbin Medisan Pharmaceutical Co., Ltd. Announces Final Cash Dividend Proposal for 2021	27/04/22
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21
Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/08/21
Harbin Medisan Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2020, Payable on July 5, 2021	29/06/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Harbin Medisan Pharmaceutical Co., Ltd.

Azioni

002900

CNE1000032V9

Altre lingue

Filtri